Envision Pharma Group Hires Leading Industry Executives Dominic Marasco and Gregory Carpenter to Lead Further Expansion of the Business and Support Growing Customer Demand

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) — Envision Pharma Group (Envision) today announced the appointment of two senior executives while further expanding its global focus on M&A, technology-enabled solutions, and strategic consulting for the life sciences industry. Dominic “Nick” Marasco has joined as Chief Commercial Officer of Envision Pharma Group, and member of the Executive […]

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) — Envision Pharma Group (Envision) today announced the appointment of two senior executives while further expanding its global focus on M&A, technology-enabled solutions, and strategic consulting for the life sciences industry.

Dominic “Nick” Marasco has joined as Chief Commercial Officer of Envision Pharma Group, and member of the Executive Leadership Team. Nick is an experienced global commercial leader with nearly 30 years of pharmaceutical, biotech, and medical device industry experience. Having held several C-suite positions, he has a proven track record of successfully launching and growing products and solutions with a focus on driving profitable revenue growth, building, and leading high-performing commercial organizations.

Nick will lead the development of Envision’s commercial-to-customer strategy while identifying new pathways to progression, with a focus on continuing its revenue growth and expanding its customer reach and solutions. He will help develop, lead, and reinforce Envision’s position as a technology-enabled commercialization, data analytics, and integrated medical capabilities and solutions company. Another key part of his role is to implement a coordinated and integrated sales structure across Envision to reinforce its technology-enabled positioning.

Before joining Envision, Nick served as Chief Commercial Officer of BioAgilytix, supporting three buyer-side acquisitions and integrations, as well as one sell-side sale of BioAgilytix to new private equity owners. Prior to BioAgilytix, he served as Executive Vice President, Global Business Development, Commercial at Syneos Health, where he led the overall strategic direction of the global business development team for the commercial division, both in the US and internationally.

Nick was also previously Head of US Sales for the Neuroscience Business Unit at Amgen, and prior to that Global Commercial Head, Amgen Biosimilars. He has also held executive-level commercial and business development positions at Sandoz Biopharmaceuticals (a Novartis company) and IQVIA (formerly Quintiles).

Nick shares, “It is a distinct pleasure to join both Meg Heim and the entire team at Envision Pharma Group. Envision is a company that is experiencing phenomenal growth and high customer engagement and loyalty across each of the pillars of the organization and has continued to realize the growing demand of customer needs and advisory services. Even better, Envision has excelled at progressive innovation via services and technology to achieve a comprehensive solutions-oriented service platform. I am excited to join this dynamic team.”

Gregory “Greg” Carpenter joins Envision Pharma Group as Chief of Staff, CEO, and member of the Executive Leadership Team and brings with him a wealth of global experience and expertise.

Greg has held several leadership roles in the pharmaceutical industry and positions spanning sales, marketing, medical, and transformation. His expertise covers areas of communications, strategic planning and implementation, coalition and consensus-building leadership development, omnichannel marketing, and change management.

Before joining Envision, Greg’s most recent role was leading a go-to-market transformation for the Sanofi US General Medicines team that included building an enterprise artificial intelligence (AI) solution, and helping the organization understand and embrace omnichannel marketing.

Greg says, “I am delighted to join Envision Pharma Group and help carry out our mission of improving lives through a compelling combination of technology and services to enable clients to better serve patients. Through our expertise in scientific and commercialization strategy and solutions, medical affairs, and AI-driven technology solutions, Envision is helping our customers to excel in a rapidly changing healthcare environment.”

Meg Heim, Chief Executive Officer of Envision Pharma Group, adds, “I am so excited to welcome Nick and Greg to the Envision team. These new positions are critical to the fulfillment of our business expansion, mission, as well as being a commitment to our vision that enables us to execute upon our strategic plans.”

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, technology-enabled commercialization, integrated medical capabilities and solutions, and HEOR data analytics, partner to the life-science industry. As a leading provider of evidence-based scientific communication services and industry-leading technology solutions, and strategic consulting that have applicability across the full pharmaceutical industry spectrum and related functional responsibility, Envision provides solutions to over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Learn more at www.envisionpharmagroup.com.

Contact Information:
Colleen Carter
Communications
colleen.carter@envisionpharma.com
1 (203) 480 0080

This content was issued through the press release distribution service at Newswire.com.

GlobeNewswire Distribution ID 8739860

Acronis Announces Sponsorship of MSP EXPO Florida 2023

Acronis signs on as a gold sponsor for the communications and digital transformation event of the year FORT LAUDERDALE, Fla., Jan. 31, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, announced today that it will be a gold sponsor at the MSP EXPO, held February 14-17, 2023 at the Broward County Convention Center […]

Acronis signs on as a gold sponsor for the communications and digital transformation event of the year

FORT LAUDERDALE, Fla., Jan. 31, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, announced today that it will be a gold sponsor at the MSP EXPO, held February 14-17, 2023 at the Broward County Convention Center in Fort Lauderdale, Florida. Collocated with ITEXPO, #TECHSUPERSHOW MSP EXPO is The Premier Conference and Networking Summit for MSPs – where MSP business owners and technology specialists share strategies to grow their managed services businesses.

Meet Acronis at MSP EXPO booth 735 to learn more about the company’s unified data protection and cybersecurity solutions which deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. There will be a very special guest appearance by NFL sports legend and former Miami Dolphins running back, Ronnie Brown, at Acronis booth 735 on Thursday, February 16 from 3:00 – 5:00 pm ET. Be sure to stop by to get your signed autograph!

In addition to Acronis’ representation as a gold sponsor for the event, the company’s ISV Technical Evangelist, James Abercrombie, will take part in two informative panel discussions. The first, taking place on Tuesday, February 14 at 1:30 pm ET in room 303B will take a deep dive into Securing Microsoft365 Environments. In this session, attendees will learn what Microsoft’s security solutions can do, what they can’t, and how MSPs can help their customers understand whether they need third-party security solutions to fill gaps. The other panel discussion, taking place on Wednesday, February 15 at 10:30 am ET in room 303B will explore New Opportunities in Cloud Storage. This session will discuss business storage needs, different cloud storage options and new models, and how MSPs can benefit from the ever-increasing need for storage and backup services.

For more than 20 years, executives, technology buyers, sellers, resellers, and manufacturers from companies of all sizes and industries assemble at ITEXPO to forge new business partnerships, collaborate and learn together and from one another. Dozens of conference sessions, keynotes, and panels will be focused on helping attendees move their businesses forward.

“Acronis is ecstatic to be the Gold Sponsor of the 2023 MSP Expo,” said Florence Jule, Senior Director of Global Partner Programs at Acronis. “2023 marks a monumental year as the 20th anniversary of Acronis. We invite all MSP Expo attendees to visit booth 735 to learn our integrated cyber protection solution that reduces complexity with a single-agent platform. As a channel-focused organization, MSPs are the heart of our business. We pride ourselves on providing a robust partner program that help MSPs grow and provides all the training and marketing tools necessary to reach their profit goals. As we celebrate two decades of innovation, we’re excited to network and discover how we can further partner together to grow our businesses in the IT channel.”

Registration for MSP EXPO is now open. Use code “Acronis25”, or the following link, for 25% off #TECHSUPERSHOW All Access Superpass: https://www.tmcnet.com/scripts/events/registration.aspx?theplan=ITMSP0223-AS&sc=Acronis25

For more information on sessions and panels, or to view the full agenda, visit: https://www.mspexpo.com/east/agenda.aspx

For the latest MSP EXPO news, updates and information follow the event on Twitter at @MSPEXPO.

About Acronis
Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment – from cloud to hybrid to on premises – at a low and predictable cost.

Acronis is a Swiss company, founded in Singapore. Celebrating two decades of innovation, Acronis has more than 2,000 employees in 45 locations. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by 16,000 service providers to protect over 750,000 businesses.

About TMC
Through education, industry news, live events and social influence, global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. As a result, leading technology vendors turn to TMC for unparalleled branding, thought leadership and lead generation opportunities. Our in-person and online events deliver unmatched visibility and sales prospects for all participants. Through our custom lead generation programs, we provide clients with an ongoing stream of leads that turn into sales opportunities and build databases. Additionally, we bolster brand reputations with the millions of impressions from display advertising on our news sites and newsletters. Making TMC a 360-degree marketing solution, we offer comprehensive event and road show management services and custom content creation with expertly ghost-crafted blogs, press releases, articles and marketing collateral to help with SEO, branding, and overall marketing efforts. For more information about TMC and to learn how we can help you reach your marketing goals, please visit www.tmcnet.com and follow us on FacebookLinkedIn and Twitter @tmcnet.

Media and Analyst Contact:
Michelle Connolly
Senior Marketing Manager
203.852.6800 ext.170
rconnolly@tmcnet.com

Acronis Contact:
Karl Bateson
Director of Global Communications
karl.bateson@acronis.com

GlobeNewswire Distribution ID 8739444

Innovations improve field productivity and subcontractor management for better cost and schedule certainty

Newest enhancements to InEight’s construction project management platform bring better forecasting accuracy, improved field collaboration, and more visibility and control over subcontractor performance. SCOTTSDALE, Ariz., Jan. 31, 2023 (GLOBE NEWSWIRE) — InEight Inc., a global leader in construction capital project management software, has announced its latest suite of software innovations, which are designed to increase […]

Newest enhancements to InEight’s construction project management platform bring better forecasting accuracy, improved field collaboration, and more visibility and control over subcontractor performance.

SCOTTSDALE, Ariz., Jan. 31, 2023 (GLOBE NEWSWIRE) — InEight Inc., a global leader in construction capital project management software, has announced its latest suite of software innovations, which are designed to increase forecasting accuracy, field productivity, and subcontractor management.

These latest updates provide contractors with a higher level of forecasting accuracy based on up-to-date project progress, including subcontractor activity. This allows for quick reactions to financial and productivity challenges, providing greater confidence to project owners.

Uncertain economic conditions and disruptions in the construction supply chain are putting increased pressure on contractors and owner/operators to produce accurate project forecasts. InEight is building on its already strong legacy in cost forecasting with significant new capabilities in the areas of time-phased forecasting, custom forecasting methods, and resource-based forecasts.

In addition to out-of-the-box forecast methods, InEight users can now configure the best equations to automate forecast calculations for the different types of work through different stages of completion. “There is no one-size-fits-all approach when it comes to forecasting, even within a single project,” says John Upton, Director Project Cost Management at InEight. “InEight helps contractors and owners better capture field data and measure progress,”

The platform enhancements also drive increased productivity through more efficient collaboration between the office and the field. Scope and quantities, productivity goals, and more are easily communicated in daily digital plans to field crews and subcontractors. Controlled transparency allows teams to identify and troubleshoot challenges. This leads to a higher level of profitability potential.

Additionally, InEight made it easier to get full visibility into subcontractor costs. With line of sight to both committed and uncommitted costs, users can compare the variance between the planned cost and the actual costs.

“Our goal is to connect scope, cost, and schedule on a single platform, giving project stakeholders the ability to collaborate effectively and deliver projects with predictable results,” comments Brad Barth, Chief Product Officer at InEight.

About InEight

InEight provides field-tested project management software for the owners, contractors, engineers and designers who are building the world around us. Over 575,000 users and more than 850 customers worldwide rely on InEight for real-time insights that help manage risk and keep projects on schedule and under budget across the entire life cycle.

From pre-planning to design, from estimating to scheduling, and from field execution to turnover, InEight has powered more than $1 trillion in projects globally across infrastructure, public sector, energy and power, oil, gas and chemical, mining, and commercial. For more information, follow InEight on LinkedIn or visit InEight.com.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

InEight Innovations Introduction: Brad Barth, Chief Product Officer at InEight, talks why constant innovation is core to our software solutions

Media Contact:

Linda Coy, Global Marketing Director, InEight press@ineight.com

GlobeNewswire Distribution ID 8739155

Citeline to Unveil Capabilities of New Clinical Trial Workflow Solution at SCOPE 2023 in Orlando 

Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) — At the Summit for Clinical Ops Executives (SCOPE) Feb. 6-9 in Orlando, Citeline will reveal details of its soon-to-be-released clinical feasibility workflow solution. The […]

Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) — At the Summit for Clinical Ops Executives (SCOPE) Feb. 6-9 in Orlando, Citeline will reveal details of its soon-to-be-released clinical feasibility workflow solution. The new technology leverages insights from Citeline’s industry-leading clinical trial benchmark data and real-world patient data with AI/ML technology to improve accuracy and predictability in progressively complex and accelerated clinical trial programs.

“Citeline is on an exciting transformational journey as a data intelligence and predictive clinical trial workflow solution provider,” said Alexandra Charge, Global Head of Clinical Planning and Patient Engagement & Recruitment. “The feasibility and clinical trial recruitment challenge is complex and ever present. Modernizing feasibility with AI and data science, unlocking the power of client data together with Citeline’s trusted industry-leading intelligence and real-world data, all enabled within a smart workflow, is key to addressing these complexities.”

The next-generation solution will help study leaders address ever-increasing complexity in enrollment projections, ensure success in selecting high-enrolling sites to accelerate timelines, and quickly identify and mitigate risks. It incorporates insights from Citeline’s industry-leading clinical trial benchmark data, real-world patient data and AI/ML technology within an intuitive user workflow interface to improve efficiency and accuracy of recruitment plans. Key attributes are used to determine overall trial success, from modern feasibility planning to study recruitment.

“Citeline’s new predictive enrollment modeling technology enables data-driven decisions and earlier identification of risks, ultimately leading to better trial success,” Charge said.

SCOPE attendees can learn more at the following Citeline sessions:

  • Human-enabled AI with Interactive Real-world Data and Technology, Feb. 7 at 2:45 p.m.: an interactive panel of AI and pharma experts will discuss using modern feasibility tools to reduce future risk
  • Transforming Patient Engagement & Recruitment for Lean Clinical Trials, Feb. 8 at 12:50 p.m.: a strategy-focused session, in partnership with Incyte, on what it takes to operationalize a seamless, trustworthy clinical trial experience

Attendees can visit the Citeline booth or talk to any of Citeline’s experts attending SCOPE to learn how Citeline can help with the ever-growing complexity of feasibility and forecasting — whether per study, portfolio or across the entire enterprise. Citeline’s anticipated next-generation predictive technology solution is scheduled for launch later this year. However, the Feasibility as a Service (FaaS) consultation solutions have already been launched to address the challenges of protocol, country and site feasibility.

Citeline’s FaaS blends historical trial data with RWD-driven capabilities to accelerate, enhance and better inform global clinical research feasibility activities. Combined with actionable insights derived from an internal team of industry expert analysts, Citeline provides a comprehensive, consultative approach to study feasibility.

About Citeline
Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.

Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.

Citeline PR contact:
Diffusion PR for Pharma Intelligence
citeline@diffusionpr.com
(213) 318-4500

GlobeNewswire Distribution ID 8738883

Presagis Introduces VELOCITY 5D Plugin for Unreal Engine

Enables Geospatially Accurate 3D Simulations with Digital Twins MONTREAL, Jan. 31, 2023 (GLOBE NEWSWIRE) — Presagis, developer of the VELOCITY 5D (V5D) digital twin production platform, today announced availability of the V5D Plugin for Unreal Engine, the most powerful 3D computer graphics engine on the market today. The plugin enables users to load a GIS-generated […]

Enables Geospatially Accurate 3D Simulations with Digital Twins

MONTREAL, Jan. 31, 2023 (GLOBE NEWSWIRE) — Presagis, developer of the VELOCITY 5D (V5D) digital twin production platform, today announced availability of the V5D Plugin for Unreal Engine, the most powerful 3D computer graphics engine on the market today. The plugin enables users to load a GIS-generated V5D digital twin into Unreal Engine to create highly realistic visualizations and simulations of entire cities and even countries.

“The primary application of the Unreal Engine Plugin will be in 3D visualization applications covering large geographic areas because of V5D’s unmatched ability to produce 3D digital twins from massive geospatial data sets,” said Jean-Michel Briere, Presagis President.

The most beneficial applications of the plugin will be in aviation, aerospace, urban planning, disaster preparation, and defense simulations that need to include expansive geographies. Visualizations that span long linear distances, such as the design of transportation routes and utility corridors, will also benefit. V5D for Unreal is the perfect extension of the scalable and highly automated, cloud based CDB production pipeline VELOCITY 5D. V5D for Unreal allow users to create custom visualization and simulation experiences in Unreal Engine while natively loading OGC CDB content produced by Velocity 5D platform or other OGC CDB compliant toolsets.

Release of the plugin is a win-win for existing users of both V5D and Unreal Engine, Briere explained. V5D users will be able to make powerful 3D fly-throughs and immersive simulations of their GIS-based digital twins. Unreal Engine users can now incorporate geospatially accurate cityscapes and terrains into their 3D experiences.

Launched in November 2022 by Presagis, V5D is a cloud-based platform that quickly and automatically converts massive volumes of geospatial data into high-fidelity 3D digital twins. With no geospatial processing expertise, V5D users can easily produce accurate digital twins from multiple 2D data sets, including GIS vector layers, remote sensing imagery, and other structured and unstructured data of any size, format, or type.

Developed by Epic Games, Unreal Engine is the 3D computer graphics generator that powers many of the world’s most popular and successful video games. Due to its vivid graphics and extremely accurate spatial presentation capabilities, Unreal Engine is increasingly being employed in other industries using 3D visualization and simulation technologies for improved understanding of current or future situations, risks and conditions.

Presagis will demonstrate the Unreal Engine plugin along with the unmatched speed, scalability, and realism of the V5D platform in booth #340 at GeoWeek 2023 being held February 13-15 in Denver, Colorado.

To learn more about the V5D Unreal Engine Plugin, please visit: https://www.presagis.com/en/product/v5d-unreal/.

About Presagis:

PRESAGIS is a global leader providing advanced 3D modeling and simulation, and embedded software solutions to the aerospace, defense, security, critical infrastructure, and GIS markets. PRESAGIS combines an open simulation development framework with expert professional services to help customers build vast dynamic virtual environments, deliver game-quality immersive simulations – all the while streamlining workflows and reducing risks. PRESAGIS recently launched cloud-based VELOCITY 5D platform quickly and automatically converts massive volumes of 2D geospatial data into high-fidelity 3D digital twins. V5D leverages artificial intelligence and game engine technology to run complex visualization and simulation scenarios that derive context from the digital twins. PRESAGIS is also at the forefront of avionics software design for certifiable cockpit displays, and, together with its 3D modeling and simulation offerings, serves hundreds of customers worldwide, including many of the world’s most respected organizations such as Boeing, Lockheed Martin, Airbus, BAE Systems, and CAE. For more information, visit www.presagis.com.

Media Contact:
Carlos Carpio, Director of Marketing and Communications: +1 514.222.0593
carlos.carpio@presagis.com

GlobeNewswire Distribution ID 8739215